NeuroNews issue 43 – US

121
Highlights: 
  • A closer look at the latest clinical data regarding flow diversion technologies – including new insights on the Flow redirection endoluminal device (FRED; MicroVention/Terumo) and five-year results from the SCENT trial (Stryker Neurovascular)
  • The unique ethical considerations created by an emergence of remote stroke interventions
  • The “new world” that Synchron’s brain-computer interface technology, the Stentrode device, could open up in neurovascular therapy
  • Profile: Else Charlotte Sandset (Oslo, Norway)
  • Neuromodulation: a special edition dedicated to the most significant research and innovations seen in the spinal cord stimulation (SCS) field recently

LEAVE A REPLY

Please enter your comment!
Please enter your name here